Associated Papers
ERBB family fusions are recurrent and actionable oncogenic targets across cancer types.
Schubert L et al.
Frontiers in Oncology, 2023
37168365 (PubMed )
Supplement: Table_3.xlsx › ERBB2_mutations
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
Jia L et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2019
30980040 (PubMed )
Supplement: NIHMS1523944-supplement-1.xlsx › Sheet1
Somatic mutations in benign breast disease tissue and risk of subsequent invasive breast cancer.
Rohan TE et al.
British Journal of Cancer, 2018
29872146 (PubMed )
Supplement: 41416_2018_89_MOESM2_ESM.xls › Table_2a
Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.
Carlo MI et al.
Clinical Genitourinary Cancer, 2017
Select a paper to view details